weekly digest may 1 to 3

Regulatory  ·  weekly digest may 1 to 3
Pfizer and Genmab’s ADC Tivdak receives full FDA approval for recurrent or metastatic cervical cancer

Weekly Digest – May 2024 Weekly Digest – May 2024 30 Apr 2024: Pfizer and Genmab’s ADC Tivdak receives full FDA approval for recurrent or metastatic cervical cancer FDA grants full approval to Pfizer and Genmab’s Tivdak for recurrent or […]

by Sandhya Ramalingam

Continue Reading
Clinical  ·  weekly digest may 1 to 3
AstraZeneca, Daiichi tout Enhertu trial win in earlier, broader HER2-low breast cancer

Weekly Digest – May 2024 Weekly Digest – May 2024 29 Apr 2024: AstraZeneca, Daiichi tout Enhertu trial win in earlier, broader HER2-low breast cancer AstraZeneca and Daiichi Sankyo’s drug Enhertu shows effectiveness against HR+ metastatic breast cancer with low […]

by Sandhya Ramalingam

Continue Reading